New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.

As more Americans turn to GLP-1 drugs like Ozempic to lose weight, McDonald’s could see as much as a $428m annual impact to revenue.

Experts have issued an urgent warning about a symptom that can come to light from taking drugs such as Mounjaro and Ozempic.

If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should ...